Corticotropin-releasing hormone ( Crh ) maps to mouse Chromosome 3 by Knapp, Lauren T. et al.
Mammalian Genome 4, 615-617 (1993). 
~enome 
@ Spfinger-Veflag New York Inc. 1993 
Corticotropin-releasing hormone (Crh) maps to mouse Chromosome 3 
Lauren T. Knapp, 1 Catherine E. Keegan, 1'2 Audrey F. Seasholtz, 3 and Sally A. Camper I 
1Department of Human Genetics, University of Michigan Medical School, Ann Arbor, Michigan 48109-0618, USA 
ZGraduate Program in Cellular and Molecular Biology, University of Michigan Medical School, Ann Arbor, Michigan 48109-0618, USA 
3Department of Biological Chemistry and Mental Health Research Institute, University of Michigan Medical School, 
Ann Arbor, Michigan 48109-0618, USA 
Received: 26 May 1993 / Accepted: 10 June 1993 
The mammalian stress response is mediated in large 
part via the hypothalamus-anterior pituitary-adrenal 
(HPA) axis. The key hypothalamic releasing factor in 
this axis is corticotropin-releasing hormone (CRH) 
(Vale et al. 1983). This 41-amino-acid peptide is re- 
leased from the median eminence and transported via 
the hypophyseal portal blood system to the anterior 
pituitary, where it increases synthesis of pro-opiomel- 
anocortin mRNA and secretion of adrenocorticotropin 
(ACTH; Vale et al. 1981). ACTH stimulates the pro- 
duction of glucocorticoids in the adrenal cortex. In 
addition to the role of CRH within the HPA stress 
axis, CRH is expressed in many other regions within 
the central nervous system where it is thought to in- 
fluence behavioral, autonomic, and immunological re- 
sponses to stress (Brown and Fisher 1985; Irwin et al. 
1992; Koob and Bloom 1985). 
CRH has been assigned to human Chromosome 
(Chr) 8 by Southern blot analysis of somatic cell hy- 
brids and localized to band 8q13 by in situ hybridiza- 
tion of metaphase chromosomes (Arbiser et al. 1988). 
Synteny homology between mice and humans sug- 
gested that Crh would map to mouse Chr 3, 4, 8, or 15 
(Nadeau et al. 1992). 
We mapped Crh to mouse Chr 3 using a M. spretus 
i n t e r s p e c i f i c  b a c k c r o s s  (C57BL/6J- tg9257 • 
SPRET/Ei) • C57BL/6J (Bain et al. 1993; Barrow et 
al. 1993). This cross was previously typed at four loci 
on distal Chr 3, Gba, Hsd3b, Tshb, and Amy-1 (Bain et 
al. 1993). We extended the characterization of this 
cross by typing two markers on proximal Chr 3, car- 
bonic anhydrase 2 (Car-2) and interleukin 2 (II-2). 
Southern blot hybridization was used to map Crh and 
Car-2, an enzyme that catalyzes the reversible hydra- 
tion reaction of carbon dioxide to bicarbonate, (Fig. 1; 
Venta et al. 1985). II'2, a lymphokine that induces ac- 
tivated T-cells to complete the cell cycle, was mapped 
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by PCR (Fig. 1; Dietrich et al. 1992; Fiorentino et al. 
1989). Haplotype analysis of 53 animals and minimi- 
zation of crossover frequency was used to deduce the 
gene order and genetic distance (cM): Crh, Car-2-11.3 
+- 4.4-I1-2-22.6 + 5.7-Gba. The map constructed from 
these data (Fig. 2) is consistent with the location pre- 
sented for Car-2, II-2, and Gba on the consensus map 
(Meisler and Seldin 1991), although these genes have 
not been previously localized relative to one another. 
Three carbonic anhydrase genes have been localized 
in close proximity on human Chr 8 and mouse Chr 3 
(Beechey et al. 1990; Eicher et al. 1976; Nakai et al. 
1987). Our observation that Car-2 and Crh cosegregate 
extends the synteny conservation between mouse Chr 
3 and human Chr 8. 
It is difficult to predict the phenotypes that might 
result from Crh mutations because of the multiple 
roles of CRH within the HPA axis and central nervous 
system. Human clinical studies suggest that hypotha- 
lamic CRH deficiency can result in adrenocortical in- 
sufficiency and hypopituitarism (Fehm et al. 1976). 
Animal studies suggest that other consequences of 
CRH deficiency are possible. For example, impaired 
synthesis and secretion of CRH in the paraventricular 
nucleus of the hypothalamus of the Lewis (LEW/N) 
rat leads to an increased susceptibility to streptococcal 
cell wall-induced arthritis (Sternberg et al. 1989). The 
expression of CRH in multiple regions of the mouse 
brain and in some peripheral tissues beginning at em- 
bryonic day 13.5 suggests that CRH expression may 
also play an important role in development (C. Kee- 
gan, unpublished data). Therefore, a deficiency of 
CRH could result in a variety of phenotypes, and a 
total loss of CRH function could potentially be lethal. 
Increased CRH activity often results in hypercortiso- 
lism. In humans, hypercortisolism is associated with 
Cushing's syndrome and is characterized by truncal 
obesity, muscle wasting, and decreased fertility (Nel- 
son 1989). A similar phenotype was observed in trans- 
genic mice that overexpress CRH (Stenzel-Poore et al. 
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1992). High levels of ectopic CRH expression in tran- 
skaryotic rats caused marked adrenal cortical hyper- 
plasia and anterior pituitary corticotrope hyperplasia 
and hypertrophy (Asa et al. 1992; Hammer et al. 1992). 
Finally, hypersecretion of CRH is thought to play a 
role in clinical depression and anorexia nervosa, sug- 
gesting that animals with increased CRH levels would 
exhibit altered motor activity, feeding, and sexual be- 
havior (Gold and Chrousos 1985; Krahn et al. 1986, 
1990; Levine et al. 1983; Nakahara 1983; Nemeroff et 
al. 1984; Sirinathsinghji et al. 1983; Sutton et al. 1982). 
Two mutations are located on proximal mouse Chr 
3, cocoa (coa) and subtle gray (sut) (Meisler and Seldin 
1991). The phenotypes of these two mutants do not 
correlate with those suggested for CRH deficiency 
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Fig. 2. The haplotype distribution of 53 animals was used to deter- 
mine gene order. The number of animals observed with each hap- 
lotype is listed below the schematic of the chromosome. The 
C57BL/6J and SPRET/Ei alleles are depicted at each locus tested by 
closed or open boxes, respectively. All other gene orders resulted in 
multiple double-crossover events. The genetic distance (cM) and 
standard error were calculated as previously described (Buckwalter 
et al. 1991). The locations of the human genes are given in paren- 
theses (Arbiser et al. 1988; Ginns et al. 1985; Nakai et al. 1987; 
Seigel et al. 1984). 
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Fig. 1. Polymorphisms used to type backcross progeny on Chr 3. 
Car-2 and Crh were typed with RFLPs detected by Southern blot 
analysis, and II-2 was typed with a simple sequence repeat polymor- 
phism detected by PCR. Gba was previously localized by PCR (Bain 
et al. 1993). Southern blots were performed as previously described 
(Sambrook et al. 1989). All gels were transferred to Zeta-Probe ny- 
lon fdters (Bio-Rad). Probes were labeled by the random hexanu- 
cleotide method (Feinberg and Vogelstein 1982). Hybridization was 
carried out at 65~ The mouse Crh cDNA probe, pGem4ZPst578 
(Seasholtz et al. 1991), revealed a polymorphism in genomic DNA 
digested with PstI. The 'SPRET/Ei and C57BL/6J alleles produced 
hybridizing fragments of 2.6 and 0.5 kb, respectively. A mouse 
cDNA clone for Car-2, pBSMACII-Sph, provided by P. Venta, 
(Venta et al. 1985), detected an SspI polymorphism. The SPRET/Ei 
specific alleles revealed fragments of 4.2, 3.1, and 0.9 kb, and the 
C57BL/6J specific alleles revealed 4.2, 3.2, 1.0, and 0.7 kb frag- 
ments. II-2 was mapped by PCR using 500 ng of mouse genomic 
DNA as a template in a 25-~1 reaction volume with 10 ~mol of each 
primer and 2 ~mol each of dATP, dCTP, dGTP, and dTTP. Primers 
for 11-2 (D3Mit21) were extended with 1-2 U of Taq polymerase 
(Dietrich et al. 1992). The amplification products were fractionated 
through 8% polyacrylamide and visualized by ethidium bromide 
staining. The amplification products were 217 and 265 bp for 
SPRET/Ei DNA and 237 bp for C57BL/6J DNA. A subset of animals 
were typed at II-2 by PCR with the same primers radiolabeled with 
~/32 P-ATP and the amplification products visualized by autoradiog- 
raphy as previously described (Buckwalter et al. 1992). Arrowheads 
designate the M. spretus-specific alleles present in genomic DNA 
from (C57BL/6J-tg9257-SPRET/Ei • C57BL/6J) F1 mice (SB) but 
absent in C57BL/6J (BB) mice. 
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